Partner data room · SNV-101 · Drug-resistant epilepsy

The benefits of ketogenic diet therapy, as a daily oral drug

SNV-101 is a once-daily oral drug designed to deliver the benefits of ketogenic diet therapy without the diet, taken alongside existing antiseizure medicines.

In this briefing

Single-dose ketone exposure against published ketone products
In vivo seizure protection
How ketosis acts on seizure circuits
Indications, market breadth and development plan

Access the briefing

For pharmaceutical, biotech and investment professionals. Use your work email.

I have an access code

Senovia will use these details only to follow up about this program. Nonconfidential summary. Composition, study reports and patent claim charts are shared under a confidentiality agreement.